Oct 6, 2020
This month, we reflect on some of the standout events
from September in the pharmaceutical industry, highlighting
shifting public perceptions of the industry, exploring the FDA's
pushback against counterfeit medications, and providing an update
on the latest COVID-19 vaccine developments.